Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms

Current Neuropharmacology

Volumn 12, Issue 1, 2014, Pages 44-56

  Verma, Vivek ^a   Singh, Nirmal ^a   Singh Jaggi, Amteshwar ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Diabetic neuropathy; Neuropathic pain; Post herpetic neuralgia; Pregabalin

Indexed keywords

AMITRIPTYLINE; DULOXETINE; GABAPENTIN; PREGABALIN;

ATAXIA; ATRIOVENTRICULAR BLOCK; BLURRED VISION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); COORDINATION DISORDER; DIABETIC NEUROPATHY; DIZZINESS; DRUG WITHDRAWAL; FIBROMYALGIA; HEADACHE; HEART FAILURE; HUMAN; MULTICENTER STUDY (TOPIC); NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOMNOLENCE; SYNAPTIC TRANSMISSION; TRIGEMINUS NEURALGIA; WEIGHT GAIN; XEROSTOMIA;

EID: 84896707910     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X1201140117162802     Document Type: Review

References (132)

1. Jaggi, A. S., Singh, N. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology, 2012, 291, 1-9. dx. doi. org/10. 1016/j. tox. 2011. 10. 019.
2. Tassone, D. M., Boyce, E., Guyer, J., Nuzum, D. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Clin. Ther., 2007, 29, 26-48. dx. doi. org/10. 1016/j. clinthera. 2007. 01. 013.
3. Shibahara, H., Ando, A., Suzuki, S., Uematsu, N., Nishimura, D. Oxycodone and pregabalin using transdermal fentanyl patch provided relief of symptoms forpostherpetic neuropathic pain in a patient with non-small cell lung cancer. Gan To Kagaku Ryoho, 2011, 38, 1675-7. PMID: 21996965.
4. Shibahara, H., Okubo, K., Takeshita, N., Nishimura, D. [Medical treatment including pregabalin and radiation therapy provided remarkable relief for neuropathic pain by brachial plexus invasion in a patient with esophageal cancer]. Gan To Kagaku Ryoho, 2012, 39, 277-80. PMID: 22333643.
5. Freynhagen, R., Strojek, K., Griesing, T., Whalen, E., Balkenohl, M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible-and fixed-dose regimens. Pain, 2005, 115, 254-63. dx. doi. org/10. 1016/j. pain. 2005. 02. 032.
6. Andre, V., Rigoulot, M. A., Koning, E. Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat. Epilepsia, 2003, 44, 893-903. dx. doi. org/10. 1046/j. 1528-1157. 2003. 61802. x.
7. Hurley, R, W., Chatterjea, D., Rose, F. M., Taylor, C. P. Gabapentin and pregabalin can interact synergistically with naproxen to produce antihyperalgesia. Anesthesiology, 2002, 97, 1263-73. dx. doi. org/10. 1097/00000542-200211000-00033.
8. Field, M. J., Cox, P. J., Stott, E., Melrose, H., Offord, J., Su, T. Z., Bramwell, S. Z., Corradini, L., England, S., Winks, J., Kinloch, R. A., Hendrich, J., Dolphin, A. C., Webb, T., Williams, D. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 17537-42. PMID: 17088553.
9. Gustafsson, H., Sandin, J. Oral pregabalin reverses cold allodynia in two distinct models of peripheral neuropathic pain. Eur. J. Pharmacol., 2009, 605, 103-8. dx. doi. org/10. 1016/j. ejphar. 2009. 01. 014.
10. Tanabe, M., Takasu, K., Takeuchi, Y., Ono, H. Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury. J. Neurosci. Res., 2008, 86, 3258-3264. dx. doi. org/10. 1002/jnr. 21786.
11. Bender, G., Florian, J. A. Jr., Bramwell, S., Field, M. J., Tan, K, K., Marshall, S., DeJongn, J., Bies, R. R., Danhof, M. Pharmacokinetic-pharmacodynamic analysis of the static allodynia response to pregabalin and sildenafil in a rat model of neuropathic pain. J. Pharmacol. Exp. Ther., 2010, 334, 599-608. dx. doi. org/10. 1124/jpet. 110. 166074.
12. Baastrup, C., Jensen, T. S., Finnerup, N. B. Pregabalin attenuates place escape/avoidance behavior in a rat model of spinal cord injury. Brain Res., 2011, 1370, 129-35. dx. doi. org/10. 1016/j. brainres. 2010. 11. 008.
13. Kawasaki-Yatsugi, S., Nagakura, Y., Ogino, S., Sekizawa, T., Kiso, T., Takahashi, M., Ishikawa, G., Ito, H., Shimizu, Y. Automated measurement of spontaneous pain-associated limb movement and drug efficacy evaluation in a rat model of neuropathic pain. Eur. J. Pain, 2012, 6(10), 1426-36. dx. doi. org/10. 1002/j. 1532-2149. 2012. 00142. x.
14. Miyazaki, R., Yamamoto, T. The Efficacy of Morphine, Pregabalin, Gabapentin, and Duloxetine on Mechanical Allodynia Is Different from That on Neuroma Pain in the Rat Neuropathic Pain Model. Anesth. Analg., 2012, 115(1), 182-8. dx. doi. org/10. 1213/ANE. 0b013e31824f94ca.
15. Plaza-Villegas, F., Heir, G., Markman, S., Khan, J., Noma, N., Benoliel, R., Patel, J., Eliav, E. Topical pregabalin and diclofenac for the treatment of neuropathic orofacial pain in rats. Oral Surg Oral Med. Oral Pathol. Oral Radiol., 2012, 114, 449-56. dx. doi. org/10. 1016/j. oooo. 2012. 05. 002.
16. Ling, B., Coudoré, F., Decalonne, L., Eschalier, A., Authier, A. Comparative antiallodynic activity of morphine, pregabalin and lidocaine in a rat model of neuropathic pain produced by one oxaliplatin injection. Neuropharmacology, 2008, 55, 724-8. dx. doi. org/10. 1016/j. neuropharm. 2008. 06. 007.
17. Peng, P., Xi, Q., Xia, S, Zhuang, L., Gui, Q., Chen, Y., Huang, Y., Zou, M., Rao, J., Yu, S. Pregabalin attenuates docetaxel-induced neuropathy in rats. J. Huazhong Univ. Sci. Technol. Med. Sci., 2012, 32, 586-90. dx. doi. org/10. 1007/s11596-012-1001-y.
18. Christoph, T., De Vry, J., Schiene, K., Tallarida, R. J., Tzschentke, T. M. Synergistic antihypersensitive effects of pregabalin and tapentadol in a rat model of neuropathic pain. Eur. J. Pharmacol., 2011, 666, 72-9. dx. doi. org/10. 1016/j. ejphar. 2011. 05. 029.
19. Luszczki JJ, Florekuszczki M. Synergistic interaction of pregabalin with the synthetic cannabinoid WIN 55, 212-2 mesylate in the hot-plate test in mice: an isobolographic analysis. Pharmacol. Rep., 2012, 64, 723-32. PMID: 22814025.
20. Lauria-Horner, B. A., Pohl, R. B. Pregabalin: a new anxiolytic. Expert Opin. Investig. Drugs, 2003, 12, 663-672. dx. doi. org/10. 1517/eoid. 12. 4. 663. 23748.
21. Bryans, J. S., Wustrow, D. J. 3-substituted GABA analogs with central nervous system activity: a review. Med. Res. Rev., 1999, 19, 149-77. dx. doi. org/10. 1002/(SICI)1098-1128(199903)19: 2<149:: AID-MED3>3. 0. CO; 2-B.
22. Moon, D. E., Lee, D. I., Lee, S. C., Song, S. O., Yoon, D. M., Yoon, M. H., Kim, H. K., Lee, Y. W., Kim, C., Lee, P. B. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study. Clin. Ther., 2010, 32, 2370-85. dx. doi. org/10. 1016/j. clinthera. 2011. 01. 014.
23. Satoh, J., Yagihashi, S., Baba, M., Suzuki, M., Arakawa, A., Yoshiyama, T., Shoji, S. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebocontrolled trial. Diabet. Med., 2011, 28, 109-116. dx. doi. org/10. 1111/j. 1464-5491. 2010. 03152. x.
24. Gilron, I., Wajsbrot, D., Therrien, F., Lemay, J. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial. Clin. J. Pain, 2011, 27, 185-93. doi: 10. 1097/AJP. 0b013e3181fe13f6.
25. Jensen, M. P., Gammaitoni, A. R., Bolognese, J. A., Alon, A., Smugar, S. S., Galer, B. S., Hewitt, D. J. The pain quality response profile of pregabalin in the treatment of neuropathic pain. Clin. J. Pain, 2012, 28, 683-6. dx. doi. org/10. 1097/AJP. 0b013e31823f9e64.
26. Rosenstock, J., Tuchman, M., LaMoreaux, L., Sharma, U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain, 2004; 110, 628-38. dx. doi. org/10. 1016/j. pain. 2004. 05. 001.
27. Frampton, J. E., Scott, L. J. Pregabalin: in the treatment of painful diabetic peripheral neuropathy. Drugs, 2004, 64, 2813-20. dx. doi. org/10. 2165/00003495-200464240-00006.
28. Richter, R. W., Portenoy, R., Sharma, U., Lamoreaux, L., Bockbrader, H., Knapp, L. E. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J. Pain, 2005, 6, 253-60. dx. doi. org/10. 1016/j. jpain. 2004. 12. 007.
29. Sharma, U., Griesing, T., Emir, B., Young, J. P Jr. Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia. Am. J. Ther., 2010, 17, 577-85. dx. doi. org/10. 1097/MJT. 0b013e3181d5e4f3.
30. Freeman, R., Durso-Decruz, E., Emir, B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care, 2008, 31, 1448-54. dx. doi. org/10. 2337/dc07-2105.
31. Rogers, L. C., Armstrong, D. G. Pregabalin for painful diabetic peripheral neuropathy. Nat. Clin. Pract. Endocrinol. Metab., 2009, 5, 14-5. dx. doi. org/10. 1038/ncpendmet1019.
32. Semel, D., Murphy, T. K., Zlateva, G., Cheung, R., Emir, B. Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies. BMC Fam. Pract., 2010, 11, 85. dx. doi. org/10. 1186/1471-2296-11-85.
33. Bansal, D., Bhansali, A., Hota, D., Chakrabarti, A., Dutta, P. Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial. Diabet. Med., 2009, 26, 1019-1026. dx. doi. org/10. 1111/j. 1464-5491. 2009. 02806. x.
34. Devi, P., Madhu, K., Ganapathy, B., Sarma, G., John, L., Kulkarni, C. Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy. Indian J. Pharmacol., 2012, 44, 51-56. dx. doi. org/10. 4103/0253-7613. 91867.
35. Biyik, Z., Solak, Y., Atalay, H., Gaipov, A., Guney, F., Turk, S. Gabapentin versus pregabalin in improving sleep quality and depression in hemodialysis patients with peripheral neuropathy: a randomized prospective crossover trial. Int. Urol. Nephrol., 2012, 45(3), 831-7. dx. doi. org/10. 1007/s11255-012-0193-1.
36. Saldaña, M. T., Pérez, C., Navarro, A. Masramón, X., Rejas, J. Pain alleviation and patient-reported health outcomes following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain in routine medical practice. Clin. Drug Investig., 2012, 32, 401-12. dx. doi. org/10. 2165/11599400-000000000-00000.
37. de Salas-Cansado, M., Pérez, C., Saldaña, M. T., Navarro, A., Rejas, J. A cost-effectiveness analysis of the effect of pregabalin versus usual care in the treatment of refractory neuropathic pain in routine medical practice in Spain. Pain Med., 2012, 13, 699-710. dx. doi. org/10. 1111/j. 1526-4637. 2012. 01375. x.
38. Navarro, A., Saldaña, M, T., Pérez, C., Torrades, S., Rejas, J. A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings. BMC Neurol., 2011, 11, 7. dx. doi. org/10. 1186/1471-2377-11-7.
39. Ogawa, S., Satoh, J., Arakawa, A., Yoshiyama, T., Suzuki, M. Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west. Drug Saf., 2012, 35, 793-806. dx. doi. org/10. 2165/11632660-000000000-00000.
40. Prettyjohns, M., Sandelin, R., Lister, S., Norrefalk, J. R. A costutility study of the use of pregabalin added to usual care in refractory neuropathic pain patients in a Swedish setting. J. Med. Econ., 2012, 15(6), 1097-109. dx. doi. org/10. 3111/13696998. 2012. 704458.
41. Baba, M., Gomyo, I. Retrospective evaluation of pregabalin for cancer-related neuropathic pain. Masui, 2012, 61, 147-54. PMID: 22413436.
42. Saif, M. W., Syrigos, K, Kaley, K, Isufi, I. Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy. Anticancer Res., 2010, 30, 2927-33. PMID: 20683034.
43. Vondracek, P., Oslejskova, H., Kepak, T, Mazanek, P., Sterba, J., Rysava, M., Gal, P. Efficacy of pregabalin in neuropathic pain in paediatric oncological patients. Eur. J. Paediatr. Neurol., 2009, 13, 332-6. dx. doi. org/10. 1016/j. ejpn. 2008. 06. 011.
44. Nakashima, T., Kiba, T., Ogawa, Y., Hosokawa, A., Shintani, H., Okada, Y., Taniguchi, T., Shigeta, M., Kozawa, K. A case of Paclitaxel-induced peripheral neuropathy successfully treated with pregabalin. Gan To Kagaku Ryoho, 2012, 39, 1443-5. PMID: 22996788.
45. Mishra, S., Bhatnagar, S., Goyal, G. N., Rana, S. P., Upadhya, S. P. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study. Am. J. Hosp. Palliat. Care, 2012, 29, 177-82. dx. doi. org/10. 1177/1049909111412539.
46. Maas, A., Ciria, J. P., Fernández, M. C., Gonzálvez, M. L., Morillo, V., Pérez, M., Masramon, X., López-Gómez, V. TENOR collaborative study group. Post hoc analysis of pregabalin vs. nonpregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health. Clin. Transl. Oncol., 2011, 13(9), 656-63. dx. doi. org/10. 1007/s12094-011-0711-0.
47. Dworkin, R. H., Corbin, A. E., Young, J. P. Jr., Sharma, U., LaMoreaux, L., Bockbrade, H., Garofalo, E. A., Poole, R. M. Pregabalin for the treatment of postherpetic neuralgia A randomized, placebo-controlled trial. Neurology, 2003, 60, 1274-1283. dx. doi. org/10. 1212/01. WNL. 0000055433. 55136. 55.
48. Sabatowski, R., Gálvez, R., Cherry, D. A., Jacquot, F., Vincent, E., Maisonobe, P., Versavel, M. 1008-045 Study Group. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebocontrolled clinical trial. Pain, 2004, 109, 26-35. dx. doi. org/10. 1016/j. pain. 2004. 01. 001.
49. Seventer, R. V., Feister, H. A., Young, J. P., Stoker, M., Versavel, M., Rigaudy, L. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13week, randomized trial. Curr. Med. Res. Opin. 2006, 22, 375-384. dx. doi. org/10. 1185/030079906X80404.
50. Edelsberg, J. S., Lord, C., Oster, G. Systematic review and metaanalysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann. Pharmacother., 2011, 45, 1483-90. dx. doi. org/10. 1345/aph. 1P777.
51. Achar, A., Chakraborty, P. P., Bisai, S., Biswas, A., Guharay, T. Comparative study of clinical efficacy of amitriptyline and pregabalin in postherpetic neuralgia. Acta Dermatovenerol. Croat., 2012, 20, 89-94. PMID: 22726281.
52. Ifuku, M., Iseki, M., Hidaka, I., Morita, Y., Komatus, S., Inada, E. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy. Pain Med., 2011, 12, 1112-6. dx. doi. org/10. 1111/j. 1526-4637. 2011. 01162. x.
53. Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P, et al. The American College of Rheumatology criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum., 1990, 33, 160-72. dx. doi. org/10. 1002/art. 1780330203.
54. Lyseng-Williamson, K. A., Siddiqui, M. A. Pregabalin: a review of its use in fibromyalgia. Drugs, 2008, 68, 2205-23. dx. doi. org/10. 2165/00003495-200868150-00009.
55. Crofford, L. J., Rowbotham, M. C., Mease, P. J., Russell, I. J., Dworkin, R. H., Corbin, A. E., Young, J. P. Jr, LaMoreaux, L. K., Martin, S. A., Sharma, U. Pregabalin 1008-105 Study Group. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum., 2005, 52, 1264-73. dx. doi. org/10. 1002/art. 20983.
56. Straube, S., Derry, S., Moore, R. A., McQuay, H. J. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports. Rheumatology (Oxford) 2010, 49, 706-15. dx. doi. org/10. 1093/rheumatology/kep432.
57. Pauer, L., Atkinson, G., Murphy, T. K., Petersel, D, Zeiher, B. Long-term Maintenance of Response Across Multiple Fibromyalgia Symptom Domains in a Randomized Withdrawal Study of Pregabalin. Clin. J. Pain, 2012, 28, 609-14. dx. doi. org/10. 1097/AJP. 0b013e31823dd315.
58. Arnold, L. M., Emir, B., Murphy, T. K., Zeiher, B. G., Pauer, L., Scott G, Petersel, D. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia. Clin. Ther., 2012, 34, 1092-102. dx. doi. org/10. 1016/j. clinthera. 2012. 03. 003.
59. Roth, T., Lankford, D. A., Bhadra, P., Whalen, E., Resnick, E. M. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study. Arthritis Care Res., (Hoboken) 2012, 64, 597-606. dx. doi. org/10. 1002/acr. 21595.
60. Lloyd, A., Boomershine, C. S., Choy, E. H., Chandran, A., Zlateva, G. The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective. J. Med. Econ., 2012, 15(3), 481-92. dx. doi. org/10. 3111/13696998. 2012. 660254.
61. Obermann M, Yoon MS, Sensen K, Maschke M, Diener HC, Katsarava Z. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia, 2008, 28(2), 174-81. PMID: 18039340.
62. Jokela, R., Ahonen, J., Tallgren, M., Haanpää, M., Korttila, K. A randomized controlled trial of perioperative administration of pregabalin for pain after laparoscopic hysterectomy. Pain, 2008, 134, 106-12. dx. doi. org/10. 1016/j. pain. 2007. 04. 002.
63. Kim, S. Y., Jeong, J. J., Chung, W. Y., Kim, H. J., Nam, K. H., Shim, Y. H. Perioperative administration of pregabalin for pain after robot-assisted endoscopic thyroidectomy: a randomized clinical trial. Surg. Endosc., 2010, 24, 2776-81. dx. doi. org/10. 1007/s00464-010-1045-7.
64. Burke, S. M., Shorten, G. D. Perioperative pregabalin improves pain and functional outcomes 3 months after lumbar discectomy. Anesth. Analg., 2010, 110, 1180-5. dx. doi. org/10. 1016/j. spinee. 2011. 04. 016.
65. Hegarty, D. A., Shorten, G. D. A Randomised, Placebo-controlled Trial of the Effects of Preoperative Pregabalin on Pain Intensity and Opioid Consumption following Lumbar Discectomy. Korean J. Pain, 2011, 24, 22-30. dx. doi. org/10. 3344/kjp. 2011. 24. 1. 22.
66. Choi, Y. S., Shim, J. K., Song, J. W., Kim, JKC., Yoo, Y. C., Kwak, Y. L. Combination of Pregabalin and Dexamethasone for Postoperative Pain and Functional Outcome in Patients Undergoing Lumbar Spinal Surgery: A Randomized Placebo-controlled Trial. Clin. J. Pain, 2012. dx. doi. org/10. 1097/AJP. 0b013e318246d1a9.
67. Romanò, C. L., Romanò, D., Bonora, C., Mineo, G. Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J. Orthop. Traumatol., 2009, 10, 185-91. dx. doi. org/10. 1007/s10195-009-0077-z.
68. Morera-Domínguez, C., Ceberio-Balda, F., Flórez-García, M., Masramón, X., López-Gómez, V. A cost-consequence analysis of pregabalin versus usual care in the symptomatic treatment of refractory low back pain: sub-analysis of observational trial data from orthopaedic surgery and rehabilitation clinics. Clin. Drug Investig., 2010, 30, 517-31. dx. doi. org/10. 2165/11536280-000000000-00000.
69. Bouwense, S. A., Olesen, S. S., Drewes, A. M., Poley, J. W., van Goor, H., Wilder-Smith, O. H. Effects of pregabalin on central sensitization in patients with chronic pancreatitis in a randomized, controlled trial. PLoS One, 2012, 7, e42096. dx. doi. org/10. 1371/journal. pone. 0042096.
70. Simpson, D. M., Schifitto, G., Clifford, D. B., Murphy, T. K., Durso-De Cruz, E., Glue, P., Whalen, E., Emir, B, Scott, G. N., Freeman, R; 1066 HIV Neuropathy Study Group. Pregabalin for painful HIV neuropathy: A randomized, double-blind, placebo-controlled trial. Neurology, 2010, 74, 413-420. dx. doi. org/10. 1212/WNL. 0b013e3181ccc6ef.
71. Zaccara, G., Perucca, P., Gangemi, P. F. The adverse event profile of pregabalin across different disorders: a meta-analysis. Eur. J. Clin. Pharmacol., 2012, 68, 903-12. dx. doi. org/10. 1007/s00228-012-1213-x.
72. Ben-Menachem, E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia, 2004, 45(suppl 6), 13-18. dx. doi. org/10. 1111/j. 0013-9580. 2004. 455003. x.
73. Zhuchenko, O., Bailey, J., Bonnen, P., Ashizawa, T., Stockton, D. W., Amos, C., Dobyns, W. B., Subramony, S. H., Zoghbi, H. Y., Lee, C. C. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltagedependent calcium channel. Nat. Genet., 1997, 15, 62-69. dx. doi. org/10. 1038/ng0197-62.
74. 2+ currents and mimics cerebellar ataxia in vivo. Proc. Natl. Acad. Sci. US. A., 2008, 105, 2705-2710. dx. doi. org/10. 1073/pnas. 0710771105.
75. Nakagawasai, O., Onogi, H., Mitazaki, S., Sato, A., Watanabe, K., Saito, H., Murai, S., Nakaya K., Murakami M., Takahashi, E., Tan-No, K., Tadano, T. Behavioral and neurochemical characterization of mice deficient in the N-type Ca2+ channel alpha1B subunit. Behav. Brain Res., 2010, 208, 224-230. dx. doi. org/10. 1016/j. bbr. 2009. 11. 042.
76. Blum, A., Simsolo, C., Tatour, I. Hyponatremia and confusion caused by pregabalin. Isr. Med. Assoc. J., 2009, 11(11), 699-700. PMID: 20108561.
77. Murphy, N., Mockler, M., Ryder, M., Ledwidge, M., McDonald, K. Decompensation of chronic heart failure associated with pregabalin in patients with neuropathic pain. J. Card Fail. 2007, 13(3), 227-9. dx. doi. org/10. 1016/j. cardfail. 2006. 11. 006.
78. Laville, M. A., de laGastine, B., Husson, B., Le Boisselier, R., Mosquet, B., Coquerel, A. Should we care about pregabalin for elderly patients with a history of cardiac dysrhythmia? Rev. Med. Interne, 2008, 29(2), 152-4. PMID: 17976866.
79. Erdoan, G., Ceyhan, D., Güleç, S. Possible heart failure associated with pregabalin use: Case report. Agri. 2011, 23(2), 80-83. PMID: 21644108.
80. Aksakal, E., Bakirci, E. M., Emet, M., Uzkeser, M. Complete atrioventricular block due to overdose of pregabalin. Am. J. Emerg. Med., 2012, 30(9), 2101. e1-4. dx. doi. org/10. 1016/j. ajem. 2012. 02. 008.
81. Furberg, C. D., Psaty, B. M., Meyer, J. V. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation, 1995, 92(5), 1326-31. dx. doi. org/10. 1161/01. CIR. 92. 5. 1326.
82. 2+ channels in the heart. Circ. Res. 2007, 101(1), 69-77. dx. doi. org/10. 1161/CIRCRESAHA. 106. 146399.
83. Skopp, G., Zimmer, G. Pregabalin-a drug with abuse potential? Arch. Kriminol., 2012, 229, 44-54. PMID: 22448469.
84. Oulis, P., Konstantakopoulos, G. Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence. Expert Opin. Investig. Drugs, 2012, 21, 1019-29. dx. doi. org/10. 1517/13543784. 2012. 685651.
85. Diamond, I., Gordon, A. S. Cellular and molecular neuroscience of alcoholism. Physiol. Rev., 1997, 77(1), 1-20. PMID: 9016298.
86. Criswell, K. A., Cook, J. C., Morse, D., Lawton, M., Somps, C., Obert, L., Roy, M., Sokolowski, S., Koza-Taylor, P., Colangelo, J., Navetta, K., Brady, J., Pegg, D., Wojcinski, Z., Rahbari, R., Duddy, S., Anderson, T. Pregabalin Induces Hepatic Hypoxia and Increases Endothelial Cell Proliferation in Mice, a Process Inhibited by Dietary Vitamin E Supplementation. Toxicol. Sci., 2012, 128, 42-56. dx. doi. org/10. 1093/toxsci/kfs148.
87. Criswell, K. A., Cook, J. C., Wojcinski, Z., Pegg, D., Herman, J., Wesche, D., Giddings, J., Brady, J. T., Anderson, T. Mode of action associated with development of hemangiosarcoma in mice given pregabalin and assessment of human relevance. Toxicol. Sci., 2012, 128, 57-71. dx. doi. org/10. 1093/toxsci/kfs149.
88. Criswell, K. A., Wojcinski, Z., Pegg, D, et al. Key components of the mode of action for hemangiosarcoma induction in pregabalintreated mice: evidence of increased bicarbonate, dysregulated erythropoiesis, macrophage activation and increased angiogenic growth factors in mice but not in rats. Toxicol. Sci., 2012, 128, 22-41. dx. doi. org/10. 1093/toxsci/kfs147.
89. Pegg, D., Bleavins, M., Herman, J., Wojcinski, Z., Graziano, M., Henck, J., Criswell. K. A., Anderson, T., Duddy, S. Hemangiosarcoma in mice administered pregabalin: analysis of genotoxicity, tumor incidence, and tumor genetics. Toxicol. Sci., 2012, 128, 9-21. dx. doi. org/10. 1093/toxsci/kfs146.
90. Catterall, W. A. Structure and regulation of voltage-gated Ca2+ channels. Annu. Rev. Cell Dev. Biol., 2000, 16, 521-55. PMID: 11031246.
91. Canti, C., Davies, A., Dolphin, A. C. The metal-ion-dependent adhesion site in the Von Willebrand factor-A domain of 2 subunits is key to trafficking voltage-gated Ca2+ channels. Curr. Neuropharmacol., 2003, 1, 209-217. doi: 10. 1073/pnas. 0504183102.
92. Halling, D. B., Aracena-Parks, P., Hamilton, S. L. Regulation of voltage-gated Ca2+ channels by calmodulin. Sci. STKE 2006, (318), er1. dx. doi. org/10. 1126/stke. 3182006er1.
93. Kang, M. G., Campbell, K. P. Gamma subunit of voltage-activated calcium channels. J. Biol. Chem., 2003, 278(24), 21315-8. dx. doi. org/10. 1074/jbc. R300004200.
94. Davies, A., Hendrich, J., Van Minh, A. T., Wratten, J., Douglas, L., Dolphin, A. C. Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels. Trends Pharmacol. Sci., 2007, 28, 220-8. dx. doi. org/10. 1016/j. tips. 2007. 03. 005.
95. Cao, Y. Q. Voltage-gated calcium channels and pain. Pain, 2006, 126, 5-9. dx. doi. org/10. 1016/j. pain. 2006. 10. 019.
96. Hoppa, M. B., Lana, B., Margas, W., Dolphin, A. C., Ryan, T. A. 2 expression sets presynaptic calcium channel abundance and release probability. Nature, 2012, 486(7401), 122-5. doi: 10. 1038/nature11033.
97. Newton, R. A., Bingham. S., Case, P. C., Sanger, G. J., Lawson, S. N. Dorsal root ganglion neurons show increased expression of the calcium channel alpha2delta-1 subunit following partial sciatic nerve injury. Brain Res. Mol. Brain Res., 2001, 95, 1-8. dx. doi. org/10. 1016/S0169-328X(01)00188-7.
98. Wang, H., Sun, H., Della, P, K., Benz, R. J., Xu, J., Gerhold, D. L., Holder, D. J., Koblan, K. S. Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases. Neuroscience, 2002, 114, 529-546. dx. doi. org/10. 1016/S0306-4522(02)00341-X.
99. Bauer, C. S., Nieto-Rostro, M., Rahman, W., Tran-Van-Minh, A., Ferron, L., Douglas, L., Kadurin, I., Sri, R, Y., Fernandez-Alacid, L., Millar, N. S., Dickenson, A. H., Lujan, R., Dolphin, A. C. The increased trafficking of the calcium channel subunit 2-1 to presynaptic terminals in neuropathic pain is inhibited by the 2 ligand pregabalin. J. Neurosci., 2009, 29, 4076-4088. dx. doi. org/10. 1523/JNEUROSCI. 0356-09. 2009.
100. Luo, Z. D., Chaplan, S. R., Higuera, E. S., Sorkin, L. S., Stauderman, KA., Williams, M. E., Yaksh, T. L. Upregulation of dorsal root ganglion 2 calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J. Neurosci., 2001, 21, 1868-1875. PMID: 11245671.
101. Li, C. Y., Zhang, X. L., Matthews, E. A., Li, K. W., Kurwa, A., Boroujerdi, A., Gross, J., Gold, M. S., Dickenson, A. H., Feng, G., Luo, Z. D. Calcium channel alpha(2)delta(1) subunit mediates spinal hyperexcitability in pain modulation. Pain, 2006, 125, 20-34. dx. doi. org/10. 1016/j. pain. 2006. 04. 022.
102. 2+ subunits-structure and gabapentin binding. Mol. Pharmacol., 2001, 59, 1243-1248. PMID: 11306709.
103. 2+ subunit subtypes. J. Mem. Biol., 2001, 184, 35-43. dx. doi. org/10. 1007/s00232-001-0072-7.
104. Li, C. Y., Song, Y. H., Higuera, E. S., Luo, Z. D. Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J. Neurosci., 2004, 24, 8494-8499. PMID: 15456823.
105. Nakamura, Y., Iga, K., Shibata, T., Shudo, M., Kataoka, K. Glial plasmalemmal vesicles: a subcellular fraction from rat hippocampal homogenate distinct from synaptosomes. Glia, 1993, 9, 48-56. dx. doi. org/10. 1002/glia. 440090107.
106. Danbolt, N. C. The high affinity uptake system for excitatory aminoacids in the brain. Prog. Neurobiol., 1994, 44, 377-96. dx. doi. org/10. 1016/0301-0082(94)90033-7.
107. Shigeri, Y., Seal, R. P., Shimamoto, K. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res. Brain Res. Rev., 2004, 45, 250-65. dx. doi. org/10. 1016/j. brainresrev. 2004. 04. 004.
108. Kugler P, Schmitt A. Glutamate transporter EAAC1 is expressed in neurons and glial cells in the rat nervous system. Glia, 1999, 27, 129-42. dx. doi. org/10. 1002/(SICI)1098-1136(199908)27: 2<129:: AID-GLIA3>3. 0. CO; 2-Y.
109. Danbolt, N. C. Glutamate uptake. Prog. Neurobiol., 2001, 65, 1-105. PMID: 11369436.
110. Ryu, J. H., Lee, P. B., Kim, J. H., Do, S. H., Kim, C. S. Effects of pregabalin on the activity of glutamate transporter type 3. Br. J. Anaesth., 2012, 109, 234-9. dx. doi. org/10. 1093/bja/aes120.
111. Davis, K. E., Straff, D. J., Weinstein, E. A. Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma. J. Neurosci., 1998, 18, 2475-85. PMID: 9502808.
112. Krizman-Genda, E., Gonzalez, M. I., Zelenaia, O., Robinson, M. B. Evidence that Akt mediates platelet-derived growth factordependent increases in activity and surface expression of the neuronal glutamate transporter, EAAC1. Neuropharmacology, 2005, 49, 872-82. dx. doi. org/10. 1016/j. neuropharm. 2005. 07. 014.
113. + channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur. J. Pharmacol., 2000, 400, 67-71. dx. doi. org/10. 1016/S0014-2999(00)00355-1.
114. Kweon, T. D., Kim, J. Y., Kwon, I. W., Choi, J. B., Lee, Y. W. Participation of K(ATP) Channels in the Antinociceptive Effect of Pregabalin in Rat Formalin Test. Korean J. Pain, 2011, 24, 131-6. dx. doi. org/10. 3344/kjp. 2011. 24. 3. 131.
115. Huang, C. W., Huang, C. C., Wu, S. N. The opening effect of pregabalin on ATP-sensitive potassium channels in differentiated hippocampal neuron-derived H19-7 cells. Epilepsia, 2006, 47, 720-6. dx. doi. org/10. 1111/j. 1528-1167. 2006. 00498. x.
116. McClelland, D., Evans, R. M., Barkworth, L., Martin, D. J., Scott, R. H. A study comparing the actions of gabapentin and pregabalin on the electro-physiological properties of cultured DRG neurons from neonatal rats. BMC Pharmacol., 2004, 4, 14. PMID: 15294026.
117. Dooley, D. J., Donovan, C. M., Pugsley, T. A. Stimulus-dependent modulation of [3H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J. Pharmacol. Exp. Ther., 2000, 295, 1086-1093. PMID: 11082444.
118. Martin, D. J., McClelland, D., Herd, M. B., Sutton, K. G., Hall, M. D., Lee K., Pinnock, R. D., Scott RH. Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel sub-unit expression. Neuropharmacology, 2002, 42, 353-66. dx. doi. org/10. 1016/S0028-3908(01)00181-2.
119. Lanneau, C., Green, A., Hirst, W. D., Wise, A., Brown, J. T., Donnier, E., Charles. K. J., Wood, M., Davies, C. H., Pangalos, M. N. Gabapentin is not a GABAB receptor agonist. Neuropharmacology, 2001, 41, 965-75. dx. doi. org/10. 1016/S0028-3908(01)00140-X.
120. Taylor, C. P., Angelotti, T., Fauman, E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res., 2007, 73, 137-150. dx. doi. org/10. 1016/j. eplepsyres. 2006. 09. 008.
121. Eutamene, H., Coelho, A. M., Theodorou, V., Toulouse, M., Chovet, M., Doherty, A., Fioramonti, J., Bueno, L. Antinociceptive effect of pregabalin in septic shock-induced rectal hypersensitivity in rats. J. Pharmacol. Exp. Ther., 2000, 295, 162-7. PMID: 10991974.
122. Su, T. Z., Feng, M. R., Weber, M. L. Mediation of highly concentrative uptake of pregabalin by L-type amino acid transport in Chinese hamster ovary and Caco-2 cells. J. Pharmacol. Exp. Ther., 2005, 313, 1406-1415. dx. doi. org/10. 1124/jpet. 104. 082255.
123. Taylor, C. P., Vartanian, M. G., Andruszkiewicz, R., Silverman, R. B. 3-alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents. Epilepsy Res., 1992, 11, 103-110. dx. doi. org/10. 1016/0920-1211(92)90044-T.
124. Bialer, M., Johannessen, S. I., Kupferberg, H. J. Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res., 2004, 61, 1-48. dx. doi. org/10. 1016/j. eplepsyres. 2004. 07. 010.
125. Fehrenbacher, J. C., Taylor, C. P., Vasko, M. R. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain, 2003, 105, 133-41. dx. doi. org/10. 1016/S0304-3959(03) 00173-8.
126. Ha, K. Y., Kim, Y. H., Rhyu, K. W., Kwon, S. E. Pregabalin as a neuroprotector after spinal cord injury in rats. Eur. Spine J. 2008, 17, 864-72. dx. doi. org/10. 1007/s00586-008-0653-6.
127. Park, S., Ahn, E. S., Han, D. W., Lee, J. H., Min, K. T., Kim, H., Hong, Y. W. Pregabalin and gabapentin inhibit substance P-induced NF-kappaB activation in neuroblastoma and glioma cells. J. Cell Biochem., 2008, 105, 414-23. dx. doi. org/10. 1002/jcb. 21837.
128. Muthuraman, A., Singh, N., Jaggi, A. S. Protective effect of Acorus calamus L. in rat model of vincristine induced painful neuropathy: an evidence of anti-inflammatory and anti-oxidative activity. Food Chem. Toxicol., 2011, 49, 2557-63. dx. doi. org/10. 1016/j. fct. 2011. 06. 069.
129. Muthuraman, A., Singh, N. Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: an evidence of anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory effects. BMC Complement. Altern. Med., 2011, 11, 24. dx. doi. org/10. 1186/1472-6882-11-24.
130. Takeuchi, Y., Takasu, K., Ono, H., Tanabe, M. Pregabalin, S-(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model. Neuropharmacology, 2007, 53, 842-53. dx. doi. org/10. 1016/j. neuropharm. 2007. 08. 013.
131. You, H. J., Lei, J., Arendt-Nielsen, L. Selective inhibitory effects of pregabalin on peripheral C but not A-delta fibers mediated nociception in intact and spinalized rats. Neuroscience, 2009, 164, 1845-1853. dx. doi. org/10. 1016/j. neuroscience. 2009. 09. 047.
132. Martinez, J. A., Kasamatsu, M., Rosales-Hernandez, A., Hanson, L. R., Frey, W. H., Toth, C. C. Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states. Mol. Pain, 2012, 8, 3. dx. doi. org/10. 1186/1744-8069-8-3.